|
|||||||||||||||
|
INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT International Peer Reviewed & Refereed Journals, Open Access Journal ISSN Approved Journal No: 2456-4184 | Impact factor: 8.76 | ESTD Year: 2016 Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.76 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI) |
||||||||||||||
Issue: May 2024
Volume 9 | Issue 5
Review Result and Publication of Paper within : 2-3 days
Click Here For more DetailsFor Authors
Forms / Download
Published Issue Details
Editorial Board
Other IMP Links
Facts & Figure
Impact Factor : 8.76
Issue per Year : 12
Volume Published : 9
Issue Published : 96
Article Submitted :
Article Published :
Total Authors :
Total Reviewer :
Total Countries :
Indexing Partner
Join RMS/Earn 300
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
|
Published Paper Details
|
|
| Paper Title: | Treatment Of Active Pulmonary And Extra-Pulmonary Tuberculosis with Co-morbidities in Adult Patients Admitted to The Government Tertiary Care Hospital in Mandya: A Cross-Sectional Study |
| Authors Name: | DR. AJAY GOPINATH , KAVITHA SEKAR , MADEEHA ABRAR , MIDHUNA T , DR. BLESSIN V SHERVIN |
| Download E-Certificate: | Download |
| Author Reg. ID: |
IJNRD_208672
|
| Published Paper Id: | IJNRD2311139 |
| Published In: | Volume 8 Issue 11, November-2023 |
| DOI: | |
| Abstract: | Tuberculosis (TB) has been a health problem that, despite all global efforts, they claimed 1.3 million deaths globally in 2020, with an increase to 1.4 million people in 2021. Due to difficulty in diagnosis and treatment of TB cases during Coronavirus pandemic in 2019, it reversed years of progress in the field. Tuberculosis is communicable disease caused by the bacteria Mycobacterium tuberculosis which commonly affects the lungs. The treatment of tuberculosis is complicated by many factors, and it is very crucial to evaluate the effectiveness of drug therapy to improve the quality of life for the tuberculosis patients. Adults who are suffering with multiple disease states are known to suffer more from tuberculosis infection hence, an appropriate treatment must be provided for such patients. The main objective of the study is to enhance the knowledge regarding tuberculosis’s association with co-morbidities. And also, to describe the treatment pattern involved in it. In a tertiary care hospital, a cross sectional study was conducted for a duration of 6 months which involved 90 tuberculosis affected patients with various co-morbidities. The study assesses the presence of different co-morbidities and their treatment pattern in the individual patient by collecting the data from the patient’s medical record. Statistical analysis i.e., descriptive analysis was done. The primary outcomes were to assess the prescribed drugs for the treatment of active pulmonary (PTB) and extra-pulmonary tuberculosis (EPTB) and secondary outcomes were focused on the association of tuberculosis with co-morbidities and their treatment pattern. The present study showed that among 90 patients, 30% of patients had extra-pulmonary tuberculosis and 70% of patients had pulmonary tuberculosis. The majority of the co-morbidities with tuberculosis were under respiratory system-related diseases (48.8%). Most of the patients were with anaemia (35.5%). In conclusion, co-morbidities are present in many tuberculosis patients and are associated with poor quality of life and increased morbidity. Identification and correction of co-morbidities is based on treating the underlying cause which may improve their clinical outcome. |
| Keywords: | Tuberculosis, Extra pulmonary tuberculosis, Comorbidities, National Tuberculosis Elimination Programme (NTEP), World Health Organization (WHO). |
| Cite Article: | "Treatment Of Active Pulmonary And Extra-Pulmonary Tuberculosis with Co-morbidities in Adult Patients Admitted to The Government Tertiary Care Hospital in Mandya: A Cross-Sectional Study", International Journal of Novel Research and Development (www.ijnrd.org), ISSN:2456-4184, Vol.8, Issue 11, page no.b301-b307, November-2023, Available :http://www.ijnrd.org/papers/IJNRD2311139.pdf |
| Downloads: | 000118757 |
| ISSN: |
2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar| ESTD YEAR: 2016 An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator |
| Publication Details: |
Published Paper ID:IJNRD2311139 Registration ID: 208672 Published In: Volume 8 Issue 11, November-2023 DOI (Digital Object Identifier): Page No: b301-b307 Country: Mandya, Karnataka, India Research Area: Pharmacy Publisher : IJ Publication Published Paper URL : https://www.ijnrd.org/viewpaperforall?paper=IJNRD2311139 Published Paper PDF: https://www.ijnrd.org/papers/IJNRD2311139 |
| Share Article: |
|
|
Click Here to Download This Article |
|
| Article Preview | |
|
|
|
Major Indexing from www.ijnrd.org
| Semantic Scholar | Microsaoft Academic | ORCID | Zenodo |
| Google Scholar | ResearcherID Thomson Reuters | Mendeley : reference manager | Academia.edu |
| arXiv.org : cornell university library | Research Gate | CiteSeerX | PUBLON |
| DRJI | SSRN | Scribd | DocStoc |
ISSN Details
 |
 |
|
ISSN: 2456-4184
Impact Factor: 8.76 and ISSN APPROVED
Journal Starting Year (ESTD) : 2016
DOI (A digital object identifier)
Conference
Open Access License Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Important Details
Social Media
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Join RMS/Earn 300
| Copyright © 2024 - All Rights Reserved - IJNRD |
Facebook Twitter Instagram LinkedIn